Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis

• Published in: Free radical biology & medicine 2011-10, Vol.51 (8), p.1492-1500
• Main Authors: Bai, Yong-Ping, Hu, Chang-Ping, Yuan, Qiong, Peng, Jun, Shi, Rui-Zheng, Yang, Tian-Lun, Cao, Ze-Hong, Li, Yuan-Jian, Cheng, Guangjie, Zhang, Guo-Gang
• Format: Article
• Language: English
• Subjects: Acetophenones - pharmacology; Apoptosis; Apoptosis - drug effects; Apoptosis - genetics; Caspase 3 - metabolism; Cell Line; Endothelial cells; Endothelium, Vascular - drug effects; Endothelium, Vascular - metabolism; Endothelium, Vascular - pathology; Free radicals; Gene Expression Regulation - drug effects; Gene Expression Regulation - genetics; Heme - metabolism; Humans; Hypochlorous Acid - metabolism; Imidazoles - pharmacology; Lipoproteins, LDL - metabolism; Membrane Glycoproteins - genetics; Membrane Glycoproteins - metabolism; MPO; NADPH oxidase; NADPH Oxidase 2; NADPH Oxidases - genetics; NADPH Oxidases - metabolism; p38 Mitogen-Activated Protein Kinases - metabolism; Peroxidases - genetics; Peroxidases - metabolism; Phosphorylation - drug effects; Phosphorylation - genetics; Pyridines - pharmacology; Reactive Oxygen Species - metabolism; RNA, Small Interfering - genetics; Signal Transduction; VPO1
• ISSN: 0891-5849; 1873-4596
• DOI: 10.1016/j.freeradbiomed.2011.07.004

Myeloperoxidase (MPO) is an important enzyme involved in the genesis and development of atherosclerosis. Vascular peroxidase 1 (VPO1) is a newly discovered member of the peroxidase family that is mainly expressed in vascular endothelial cells and smooth muscle cells and has structural characteristics and biological activity similar to those of MPO. Our specific aims were to explore the effects of VPO1 on endothelial cell apoptosis induced by oxidized low-density lipoprotein (ox-LDL) and the underlying mechanisms. The results showed that ox-LDL induced endothelial cell apoptosis and the expression of VPO1 in endothelial cells in a concentration- and time-dependent manner concomitant with increased intracellular reactive oxygen species (ROS) and hypochlorous acid (HOCl) generation, and up-regulated protein expression of the NADPH oxidase gp91phox subunit and phosphorylation of p38 MAPK. All these effects of ox-LDL were inhibited by VPO1 gene silencing and NADPH oxidase gp91phox subunit gene silencing or by pretreatment with the NADPH oxidase inhibitor apocynin or diphenyliodonium. The p38 MAPK inhibitor SB203580 or the caspase-3 inhibitor DEVD-CHO significantly inhibited ox-LDL-induced endothelial cell apoptosis, but had no effect on intracellular ROS and HOCl generation or the expression of NADPH oxidase gp91phox subunit or VPO1. Collectively, these findings suggest for the first time that VPO1 plays a critical role in ox-LDL-induced endothelial cell apoptosis and that there is a positive feedback loop between VPO1/HOCl and the now-accepted dogma that the NADPH oxidase/ROS/p38 MAPK/caspase-3 pathway is involved in ox-LDL-induced endothelial cell apoptosis.